» Articles » PMID: 24526887

Design, Synthesis, and in Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations

Overview
Publisher Wiley
Specialty Biology
Date 2014 Feb 15
PMID 24526887
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Based on DFT, MP2, and the density functional from Truhlar group (hybrid GGA: MPW1k) calculations for an acid-catalyzed hydrolysis of nine Kirby's N-alkylmaleamic acids and two atenolol prodrugs were designed. The calculations demonstrated that the amide bond cleavage is due to intramolecular nucleophilic catalysis by the adjacent carboxylic acid group and the rate-limiting step is determined based on the nature of the amine leaving group. In addition, a linear correlation of the calculated and experimental rate values has drawn credible basis for designing atenolol prodrugs that are bitterless, are stable in neutral aqueous solutions, and have the potential to release the parent drug in a sustained release manner. For example, based on the calculated B3LYP/6-31 G (d,p) rates, the predicted t1/2 (a time needed for 50% of the prodrug to be converted into drug) values for atenolol prodrugs ProD 1-ProD 2 at pH 2 were 65.3 hours (6.3 hours as calculated by GGA: MPW1K) and 11.8 minutes, respectively. In vitro kinetic study of atenolol prodrug ProD 1 demonstrated that the t1/2 was largely affected by the pH of the medium. The determined t1/2 values in 1N HCl, buffer pH2, and buffer pH 5 were 2.53, 3.82, and 133 hours, respectively.

Citing Articles

A Stability-Indicating Ultra Performance Liquid Chromato-Graphic (UPLC) Method for the Determination of a Mycophenolic Acid-Curcumin Conjugate and Its Applications to Chemical Kinetic Studies.

Yuyun Y, Jithavech P, Thitikornpong W, Vajragupta O, Rojsitthisak P Molecules. 2021; 26(17).

PMID: 34500831 PMC: 8433641. DOI: 10.3390/molecules26175398.

References
1.
Zhao Y, Truhlar D . Exploring the Limit of Accuracy of the Global Hybrid Meta Density Functional for Main-Group Thermochemistry, Kinetics, and Noncovalent Interactions. J Chem Theory Comput. 2015; 4(11):1849-68. DOI: 10.1021/ct800246v. View

2.
Huttunen K, Raunio H, Rautio J . Prodrugs--from serendipity to rational design. Pharmacol Rev. 2011; 63(3):750-71. DOI: 10.1124/pr.110.003459. View

3.
Karaman R, Dajani K, Qtait A, Khamis M . Prodrugs of acyclovir--a computational approach. Chem Biol Drug Des. 2012; 79(5):819-34. DOI: 10.1111/j.1747-0285.2012.01335.x. View

4.
Karaman R, Amly W, Scrano L, Mecca G, Bufo S . Computationally designed prodrugs of statins based on Kirby's enzyme model. J Mol Model. 2013; 19(9):3969-82. DOI: 10.1007/s00894-013-1929-2. View

5.
Vergin H, Nitsche V . Oral bioavailability of atenolol. J Int Med Res. 1989; 17(5):417-25. DOI: 10.1177/030006058901700503. View